SMO ClinPlus CO.,LTD. (SHE:301257)

China · Delayed Price · Currency is CNY

47.82

-0.50 (-1.03%)

May 18, 2026, 4:00 PM EDT

70.85% (1Y)

Market Cap	3.78B +74.5%
Revenue (ttm)	860.07M +8.1%
Net Income	114.23M +25.4%
EPS	1.45 +27.2%
Shares Out	79.00M
PE Ratio	33.01
Forward PE	n/a
Dividend	0.27 (0.55%)
Ex-Dividend Date	Nov 28, 2025

Volume	1,971,020
Average Volume	1,919,200
Open	48.36
Previous Close	48.32
Day's Range	47.15 - 48.64
52-Week Range	27.20 - 85.00
Beta	1.00
RSI	28.07
Earnings Date	Apr 29, 2026

About SMO ClinPlus CO.,LTD.

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2009

Employees 4,271

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301257

Full Company Profile

Financial Performance

In 2025, SMO ClinPlus CO.,LTD.'s revenue was 842.50 million, an increase of 4.82% compared to the previous year's 803.73 million. Earnings were 109.64 million, an increase of 3.01%.

Financial Statements